Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

7 Mar 2014 12:45

RNS Number : 8111B
Hiscox Ltd
07 March 2014
 

Hiscox Ltd

 

(the 'Company')

 

Notification of transactions by Directors or Person Discharging Managerial Responsibilities ('PDMRs')

 

 

Hamilton, Bermuda- The Company has been notified that on 6 March 2014, Mr. Bronek Masojada, a Director, exercised nil-cost options under the Performance Share Plan to acquire 561,861 ordinary shares of 5 55/89p each.

 

Following this transaction Mr. Masojada has a beneficial interest in 3,891,021 ordinary shares of 5 55/89p each in the Company.

 

This notice is made pursuant to DTR 3.1.4R

 

Jeremy Pinchin

 

Company Secretary

Hiscox Ltd

+ 1 441 278 8300

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBDGDXIDGBGSR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.